Full-Life Technologies Limited (“Full-Life”) is a fully integrated global radiopharmaceutical company with operations in Belgium, Germany, and China. We seek to own the entire value chain for radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients. The company plans to attack core issues affecting radiopharmaceuticals today through innovative research that targets the treatments of tomorrow. We are comprised of a team of fast-moving entrepreneurs and scientists with a demonstrated track record in the life sciences, as well as radioisotope research and clinical development.

Chengwei Capital

Yunion Health Investments

Sequoia Capital China

CD Capital

Junsan Capital

Kunlun Capital

Guanghua Wutong Fund

Prosperity7 Ventures

Dart Xia Yan Venture Capital

Junson Capital

Sky9 Capital

Summer Capital

Full-Life Technologies

Full-Life Technologies announced the recent achievement of its subsidiary “Full-Life Technology Europe” has obtained a Nuclear Permit for a class IIA facility from the Belgium Federal Agency for Nuclear Control (“FANC”), authorizing the construction and operation of this pivotal facility for producing therapeutic radioisotopes.

#FULLLIFE #NUCLEARPERMIT #FANC #RADIOISOTOPE 

Full-Life Technologies announced that preclinical data of 225Ac-FL-020 (a PSMA-targeted RDC program) will be presented in a Poster Session at the AACR (American Association for Cancer Research) Annual Meeting 2024, which will be held on Apr. 5th to 10th, 2024 in San Diego, CA.

#fulllife #AACR2024 #225Ac #RDC #PSMA

Full-Life Technologies (Full-Life), a clinical stage, fully integrated global radiotherapeutics company and Eckert & Ziegler (ISIN DE0005659700, SDAX) today announced they have entered into an agreement for the supply of Actinium-225 (Ac-225). 

#FullLife #EckertZiegler #Ac225 #SupplyAgreement #radiotherapeutics

Check out Endpoints News' story with Julie Wu, CFO of Full-Life Technologies. 

#FullLife #Radioisotope #Actinium225 #PSMA

Full-Life Technologies ("Full-Life"), a fully integrated global radiotherapeutics company, today announced the completion of $63.3 million financing, comprised of $47.3 million in Series B equity financing and $16 million in loan facilities. 

#FullLife #SeriesB #Prosperity7 #Sky9Capital #SummerCapital #GuanghuaWutongFund #ChengweiCapital #HongShan #JunsonCapital #225Ac-FL-020 #UniRDC™

Varian Medical Systems provides medical devices and software for treating cancer and other medical conditions.

Varian Medical Systems

Isoray specializes in the development and commercialization of innovative brachytherapy products for the treatment of prostate cancer.

Isoray

Advanced Oncotherapy is a developer of next-generation proton therapy systems for cancer treatment.

Advanced Oncotherapy

OZiva offers a range of health and wellness products including nutritional supplements and superfoods.

OZiva

ALOHA is a company that focuses on producing organic, plant-based nutritional products and supplements.

ALOHA

Fast&Up offers a wide range of sports nutrition products and supplements for athletes and fitness enthusiasts.

Fast&Up

CorroHealth provides healthcare software solutions for revenue cycle management and patient engagement.

CorroHealth

Accolade offers personalized healthcare advocacy and navigation services for individuals and employers.

Accolade

WellSky provides software and solutions for post-acute care, home health, and hospice organizations.

WellSky

Full Life is a leading provider of health and wellness solutions that leverage cutting-edge technology to deliver personalized care. With a focus on preventative health, the company offers a range of services including telehealth consultations, wellness tracking, and personalized fitness programs.

Full Life

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 14, 2024 7:54 AM	f21125f2
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 11, 2024 10:30 AM	545e9111
crunchbase profile	general
li profile	general	May 14, 2024 7:54 AM	1642a093
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:FULL-LIFE

Full Life